Latest Convertible Notes News

BluGlass capped FY26 with major contract wins including a $1.4 million Phase II deal with Uviquity, a $1.3 million agreement with a Fortune 500 data storage giant, and a world-record 1.9W output from its blue GaN laser, while raising $14.6 million to fuel growth.

Livium Ltd has locked in A$1.575 million in initial funding from The Lind Partners, with potential to raise up to A$11.75 million over two years, while offering shareholders a discounted share purchase plan to support its recycling growth strategy.

Cann Group reported its second-ever quarterly operating cash inflow of $0.24 million in Q4 FY2026, edging closer to cash flow break-even. The company expanded exports to the UK and Germany, launched new products, and completed a leadership transition while redeeming convertible notes and securing additional credit.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

BCAL Diagnostics has strengthened its leadership, advanced breast cancer detection tests, and secured key funding and strategic investments to underpin its FY2027 growth plans.

Sprintex boosted its commercial footprint in the June quarter with a 65% order book increase from Mest Water, a paid trial at Taiwan's TSMC, and Dutch regulatory clearance lifting key uncertainties.

Revolver Resources has completed critical design and infrastructure upgrades at its Dianne Copper Mine Project, edging closer to a Final Investment Decision and first copper production within a year.

PainChek lifted implemented ARR by 5.9% to $4.46 million and secured its first US commercial contracts under a major Sabra REIT agreement, boosting customer receipts 27% in the June quarter.

Dotz Nano has appointed Nati Harpaz as CEO, introduced Dotz Energy to extend its decarbonisation efforts, and secured $3.3 million in fresh funding to accelerate commercialisation and production scale-up.

Web Travel Group projects solid revenue and margin gains for 1H27 despite currency headwinds, backing its outlook with a substantial $90 million share buy-back.

Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.

Elevra Lithium’s North American Lithium operation hit a new monthly spodumene concentrate production record in May 2026 while closing a US$298 million financing package to fund expansion and project development.